Biogened (WAR:BGD) Cyclically Adjusted PB Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BGD Biogened SA WAR:BGD
75 GF Score
Price zł20.20
GF Value zł24.06
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Biogened Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biogened  (WAR:BGD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biogened Cyclically Adjusted PB Ratio Related Terms


Biogened Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Biogened's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogened Cyclically Adjusted PB Ratio Chart

Biogened Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.47 0.66 0.87 0.87

Biogened Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.90 0.83 0.67 0.71

WAR:BGD vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biogened's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogened Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biogened's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biogened's Cyclically Adjusted PB Ratio falls into.


WAR:BGD
75GF Score
Biogened SA WAR:BGD
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogened Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biogened's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Biogened's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=19.425/162.2800*162.2800
=19.425

Current CPI (Jun. 2026) = 162.2800.

Biogened Quarterly Data

Book Value per Share CPI Adj_Book
201609 21.791 99.064 35.697
201612 22.424 100.366 36.257
201703 20.793 101.018 33.403
201706 20.948 101.180 33.598
201709 21.008 101.343 33.640
201712 20.995 102.564 33.219
201803 21.196 102.564 33.537
201806 21.372 103.378 33.549
201809 21.412 103.378 33.612
201812 21.458 103.785 33.552
201903 21.713 104.274 33.792
201906 21.865 105.983 33.479
201909 21.892 105.983 33.521
201912 21.976 107.123 33.291
202003 22.297 109.076 33.173
202006 22.193 109.402 32.920
202009 22.322 109.320 33.136
202012 22.281 109.565 33.001
202103 22.656 112.658 32.635
202106 22.755 113.960 32.403
202109 22.779 115.588 31.981
202112 12.193 119.088 16.615
202203 23.662 125.031 30.711
202206 13.257 131.705 16.335
202209 13.381 135.531 16.022
202212 13.269 139.113 15.479
202303 14.205 145.950 15.794
202306 14.283 147.009 15.767
202309 14.523 146.113 16.130
202312 14.944 147.741 16.415
202403 15.436 149.044 16.807
202406 15.964 150.997 17.157
202409 16.006 153.439 16.928
202412 16.814 154.660 17.642
202503 17.245 157.021 17.823
202506 17.838 157.509 18.378
202509 17.841 158.000 18.324
202512 18.326 158.320 18.784
202603 19.237 163.070 19.144
202606 19.425 162.280 19.425

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Biogened (WAR:BGD) Overvalued in 2026?

Based on GuruFocus' analysis, Biogened stock appears to be undervalued. The current stock price of zł20.20 is trading 16% below its estimated GF Value™ of zł24.06. GuruFocus considers Biogened to be Modestly Undervalued.

Key valuation signals for WAR:BGD:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: zł24.06 vs. price of zł20.20 (16% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the WAR:BGD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biogened Business Description

Address Ulica Pojezierska 99, Lodz, POL, 91-342
Biogened SA is involved in manufacturing cosmetic and hygiene products. It also designs, produces, and markets safe, effective dermo-cosmetics under the Dermedic brand. The company's products include Dermocosmetics, Thermal water, and Pharmaceutical manufacturing conditions.
75GF Score

Get the complete analysis for WAR:BGD

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł20.20
Price
zł24.06
GF Value